About Us    |    TRC Technology    |    Clinical Programs    |    Investors    |    News     |    Contact

Corporate overview


  • Platform Stem Cell Technology
           Tissue Repair Cell (TRC) technology

  • Over 375 Patients Treated to Date

  • Active Clinical Trial Program

  • Comprehensive Patent Portfolio
           U.S. Patents – 26 issued, 4 pending
           Foreign Patents – 41 issued, 4 pending

  • Headquarters – Ann Arbor, Michigan